Connection

John Su to Herpes Zoster Vaccine

Back to Details
This is a "connection" page, showing publications John Su has written about Herpes Zoster Vaccine.
John Su
Connection Strength
0.329
Herpes Zoster Vaccine
  1. Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018. MMWR Morb Mortal Wkly Rep. 2019 Feb 01; 68(4):91-94.
    View in: PubMed
    Score: 0.169
  2. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015. Hum Vaccin Immunother. 2018; 14(8):1963-1969.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.